City State Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

City State Bank’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.4K	Hold	200	–	–	﹤0.01%	533
2026 Q1	$11.3K	Hold	200	–	–	﹤0.01%	526
2025 Q4	$11.9K	Hold	200	–	–	﹤0.01%	518
2025 Q3	$10.8K	Hold	200	–	–	﹤0.01%	512
2025 Q2	$11K	Hold	200	–	–	﹤0.01%	504
2025 Q1	$14.1K	Hold	200	–	–	﹤0.01%	470
2024 Q4	$13.1K	Hold	200	–	–	﹤0.01%	474
2024 Q3	$14.1K	Hold	200	–	–	0.01%	467
2024 Q2	$16.5K	Hold	200	–	–	0.01%	437
2024 Q1	$17K	Hold	200	–	–	0.01%	418
2023 Q4	$19K	Hold	200	–	–	0.01%	395
2023 Q3	$18K	Hold	200	–	–	0.01%	397
2023 Q2	$17K	Hold	200	–	–	0.01%	402
2023 Q1	$19K	Hold	200	–	–	0.01%	388
2022 Q4	$21K	Hold	200	–	–	0.01%	359
2022 Q3	$17K	Hold	200	–	–	0.01%	365
2022 Q2	$17K	Hold	200	–	–	0.01%	368
2022 Q1	$15K	Hold	200	–	–	0.01%	404
2021 Q4	$18K	Buy	+200	New	+$16.5K	0.01%	397

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

City State Bank's BMRN Position: Q2 2026 in Review

City State Bank held its BioMarin Pharmaceuticals (BMRN) position steady in Q2 2026 at 200 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #533.

City State Bank first reported a position in BMRN in Q4 2021 and has held it in 19 quarters since. The position peaked at $21K in Q4 2022. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

City State Bank held 200 shares of BioMarin Pharmaceuticals worth $11.4K as of Q2 2026.
City State Bank left its BioMarin Pharmaceuticals share count unchanged in Q2 2026.
BioMarin Pharmaceuticals made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #533 holding.
City State Bank first reported a position in BioMarin Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
City State Bank's BioMarin Pharmaceuticals position peaked at $21K in Q4 2022.
565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.